New dihydropyridine derivatives: Anti-inflammatory, analgesic and docking studies

dc.contributor.authorUlloora, S.
dc.contributor.authorKumar, S.
dc.contributor.authorShabaraya, R.
dc.contributor.authorVasudeva Adhikari, A.V.
dc.date.accessioned2026-02-05T09:34:52Z
dc.date.issued2013
dc.description.abstractThe present article describes synthesis of new diethyl 2,6-dimethyl-4-(4- (2-substituted amino-2-oxoethoxy) phenyl)-1,4-dihydropyridine-3,5-dicarboxylates (6a-10b) following multistep synthetic route. Structures of newly synthesized intermediates and title compounds were established by spectral and elemental analyses. The final compounds were screened for their in vivo anti-inflammatory and analgesic activities by carrageenan-induced paw oedema and tail immersion methods, respectively. Moreover, molecular docking studies were carried out for active compounds 6c, 6d, 7d, 8 and 10b to study their mode of action, meanwhile in vivo results indicated that these compounds displayed rapid onset of anti-inflammatory action and exhibited prominent activity when compared with the standard drug. Compounds 6d and 7d carrying amide functionality showed the highest anti-inflammatory as well as analgesic activities. The molecular docking results emphasised the in vivo data and all docked molecules were found to display very low binding constant values in nanomolar scale. © 2012 Springer Science+Business Media, LLC.
dc.identifier.citationMedicinal Chemistry Research, 2013, 22, 4, pp. 1549-1562
dc.identifier.issn10542523
dc.identifier.urihttps://doi.org/10.1007/s00044-012-0156-1
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/26799
dc.subject4 (2 (2 (4 (3,5 bis(ethoxycarbonyl) 2,6 dimethyl 1,4 dihydropyridin 4 yl)phenoxy)acetyl)hydrazinyl) 4 oxobutanoic acid
dc.subjectanalgesic agent
dc.subjectantiinflammatory agent
dc.subjectcarrageenan
dc.subjectdiclofenac
dc.subjectdiethyl 4 (4 ((5 mercapto 1,3,4 oxadiazol 2 yl)methoxy)phenyl) 2,6dimethyl 1,4 dihydropyridine 3,5 dicarboxylate
dc.subjectdiethyl 4 (4 (2 (1,3 dioxoisoindolin 2 ylamino) 2 oxoethoxy)phenyl) 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylate
dc.subjectdiethyl 4 (4 (2 (benzothiazol 2 ylamino) 2 oxoethoxy)phenyl) 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylate
dc.subjectdiethyl 4 (4 (2 (benzylamino) 2 oxoethoxy)phenyl) 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylate
dc.subjectdiethyl 4 (4 (2 (p toluidino) 2 oxoethoxy)phenyl) 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylate
dc.subjectdiethyl 4 (4 (2,6 dimethylphenylamino) 2 oxoethoxy)phenyl) 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylate
dc.subjectdiethyl 4 (n' (3 chloro thiophene 2 carbonyl) 2 phenoxyacetohydrazide) 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylate
dc.subjectdiethyl 4 (n' (4 methyl benzoyl) 2 phenoxyacetohydrazide) 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylate
dc.subjectdiethyl 4 (n' (benzoyl) 2 phenoxyacetohydrazide) 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylate
dc.subjectdiethyl 4 (n' (thiophene 2 carbonyl) 2 phenoxyacetohydrazide) 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylate
dc.subjectdiethyl 4-(4 (2 (3,5 dimethyl 1h pyrazol 1 yl) 2 oxoethoxy)phenyl) 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylate
dc.subjectdihydropyridine derivative
dc.subjectunclassified drug
dc.subjectanalgesic activity
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectantiinflammatory activity
dc.subjectarticle
dc.subjectbinding affinity
dc.subjectcarbon nuclear magnetic resonance
dc.subjectcontrolled study
dc.subjectdrug mechanism
dc.subjectdrug potency
dc.subjectdrug structure
dc.subjectdrug synthesis
dc.subjectfemale
dc.subjectimmersion
dc.subjectin vivo study
dc.subjectinfrared spectroscopy
dc.subjectmale
dc.subjectmass spectrometry
dc.subjectmolecular docking
dc.subjectnonhuman
dc.subjectpaw edema
dc.subjectproton nuclear magnetic resonance
dc.subjectrat
dc.titleNew dihydropyridine derivatives: Anti-inflammatory, analgesic and docking studies

Files

Collections